Literature DB >> 18165322

Oesophageal dilatation on high-resolution computed tomography scan of the lungs as a sign of scleroderma.

M C Vonk1, C E van Die, M M Snoeren, K J Bhansing, P L C M van Riel, J Fransen, F H J van den Hoogen.   

Abstract

BACKGROUND: Systemic sclerosis (SSc) is a generalised autoimmune disease that causes morbidity and reduced life expectancy. Recently, evidence has been accumulating that immunosuppressive treatment in an early stage of the disease could improve survival, enhancing the need for early diagnosis and regular evaluation of organ involvement. Among others, a high-resolution computer tomography (HRCT) scan of the chest is performed for the assessment of pulmonary involvement in SSc. The objective of this study is to evaluate the predictive value of oesophageal dilatation on the HRCT scan for the diagnosis of SSc.
METHODS: In total, 105 consecutive patients with scleroderma and 107 consecutive controls were included in this study. The first available scan for each patient and control was evaluated in random order and blinded for the diagnosis, by two independent radiologists, for oesophageal dilatation and interstitial lung disease.
RESULTS: The positive predictive value of oesophageal dilatation for the diagnosis of SSc was 83%. No significant correlation of oesophageal dilatation and interstitial lung disease was found in the patients with scleroderma or controls.
CONCLUSION: Oesophageal dilatation as visible on an HRCT scan of the chest may alert doctors to look for other signs or symptoms of SSc in these patients, enabling early diagnosis and specific treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18165322     DOI: 10.1136/ard.2007.081612

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

Review 1.  Systemic sclerosis--challenges for clinical practice.

Authors:  Zsuzsanna H McMahan; Laura K Hummers
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

2.  Relationship between interstitial lung disease and oesophageal dilatation on chest high-resolution computed tomography in patients with systemic sclerosis: a cross-sectional study.

Authors:  Fausto Salaffi; Marco Di Carlo; Marina Carotti; Paolo Fraticelli; Armando Gabrielli; Andrea Giovagnoni
Journal:  Radiol Med       Date:  2018-04-23       Impact factor: 3.469

Review 3.  Viewpoint: a multidisciplinary approach to the assessment of patients with systemic sclerosis-associated interstitial lung disease.

Authors:  Soumya Chatterjee; Apostolos Perelas; Ruchi Yadav; Donald F Kirby; Amandeep Singh
Journal:  Clin Rheumatol       Date:  2022-10-21       Impact factor: 3.650

4.  Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study.

Authors:  Carrie Richardson; Rishi Agrawal; Jungwha Lee; Orit Almagor; Ryan Nelson; John Varga; Michael J Cuttica; Jane D Amico Dematte; Rowland W Chang; Monique E Hinchcliff
Journal:  Semin Arthritis Rheum       Date:  2016-02-26       Impact factor: 5.532

Review 5.  Diagnosis and treatment of connective tissue disease-associated interstitial lung disease.

Authors:  Rekha Vij; Mary E Strek
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

6.  Comment on "Esophageal dilatation and interstitial lung disease in systemic sclerosis: A cross-sectional study".

Authors:  Aileen Hoffmann; Jungwha Lee; Madeleine Ma; Rishi Agrawal; Rowland W Chang; Carrie Richardson; Monique Hinchcliff; Kimberly Showalter
Journal:  Semin Arthritis Rheum       Date:  2016-05-06       Impact factor: 5.532

Review 7.  GI Manifestations With a Focus on the Esophagus: Recent Progress in Understanding Pathogenesis.

Authors:  Marie-Pier Tétreault; Peter Kahrilas
Journal:  Curr Rheumatol Rep       Date:  2019-07-03       Impact factor: 4.592

8.  Esophageal Dilatation as a Predictor of Systemic Sclerosis in Patients with Interstitial Lung Disease.

Authors:  Ana Filipa Santos Duarte de Figueiredo; João Felício Costa; António P Matos; Miguel Ramalho
Journal:  Turk Thorac J       Date:  2021-05

9.  Significance of various pulmonary and extrapulmonary abnormalities on HRCT of the chest in scleroderma lung.

Authors:  Anoop Kumar Pandey; Pearce Wilcox; Julie O' Brien; Jennifer Ellis; Jacquie Brown; Jonathon Leipsic
Journal:  Indian J Radiol Imaging       Date:  2013-10

10.  Esophageal Dilation and Other Clinical Factors Associated With Pulmonary Function Decline in Patients With Systemic Sclerosis.

Authors:  Kimberly Showalter; Aileen Hoffmann; Carrie Richardson; David Aaby; Jungwha Lee; Jane Dematte; Rishi Agrawal; Hatice Savas; Xiaoping Wu; Rowland W Chang; Monique Hinchcliff
Journal:  J Rheumatol       Date:  2021-07-15       Impact factor: 4.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.